特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
933194

ワクチンの開発と生産の動向、新型コロナウイルス感染症 (COVID-19) とその他のワクチンのパイプライン

Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline

出版日: | 発行: Kalorama Information | ページ情報: 英文 182 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
ワクチンの開発と生産の動向、新型コロナウイルス感染症 (COVID-19) とその他のワクチンのパイプライン
出版日: 2020年04月20日
発行: Kalorama Information
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
担当者のコメント
IVD市場の調査分析において長年の実績を持つ米国の調査会社、Kalorama Informationより、COVID-19およびその他の、各国におけるワクチン開発動向をまとめた最新の調査レポートがリリースされました。主要20数社における詳細のプロファイルを含め、2020年度4月発行の注目の調査レポートになります。
  • 全表示
  • 概要
  • 目次
概要

ワクチン市場は、開発中のワクチンの数と、新型コロナウイルス感染症 (COVID-19) ワクチンの強い要求により、今後5年間で大幅な増加が見込まれています。世界中でCOVID-19のアウトブレイクが進むにつれ、企業はこの難題に挑み、ワクチンの可能性を提供するために奮闘しています。

当レポートでは、ヒト用ワクチン市場について調査分析し、商品化されたワクチンと開発中のワクチンに焦点を当てて、ワクチンメーカーが直面している課題などについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 ワクチン業界のイントロダクション

  • 概要
    • ワクチンのしくみ
    • ワクチンの種類
    • 規制プロセス

第3章 ワクチン開発の生産と課題

  • ワクチン開発プログラム
    • 卵から生産
    • 細胞から生産
  • インフルエンザワクチンの生産
  • 細胞ベースのインフルエンザワクチン
  • 製造上の課題
  • パンデミック
  • 受託製造の関与

第4章 ワクチン業界の問題と動向

  • 概要
  • 平均余命の向上
  • 製造インセンティブ
  • 合成ワクチン
  • 人工知能 (AI) 開発
  • パイプラインとCOVID-19の開発

第5章 市場参入企業

  • ADVAXIS, INC
  • BAVARIAN NORDIC, A/S
  • BHARAT BIOTECH INTERNATIONAL LTD
  • CSL LIMITED/SEQIRIS
  • EMERGENT BIOSOLUTIONS, INC
  • GLAXOSMITHKLINE, INC
  • GRADALIS, INC
  • HAWAII BIOTECH, INC
  • IMMUNE RESPONSE BIOPHARMA, INC
  • NOVIO PHARMACEUTICALS, INC
  • JOHNSON & JOHNSON/CRUCELL/JANSSEN
  • MEDICAGO, INC
  • MERCK & CO, INC
  • 田辺三菱製薬
  • MODERNA, INC
  • NORTHWEST BIOTHERAPEUTICS, INC
  • NOVAVAX, INC
  • PFIZER, INC
  • SANOFI PASTEUR
  • SERUM INSTITUTE, INC
  • SOLIGENIX, INC
  • SOTIO A.S
  • 武田薬品工業
  • VALNEVA SE

付録:WHOワクチンパイプライントラッカー

目次
Product Code: 20-029

The vaccine market is poised for a rather substantial increase in the next five years due to the number of vaccines in development and the push for a COVID-19 vaccine. As the COVID-19 outbreak advanced worldwide, companies stepped up to the challenge, scrambling to provide a potential vaccine. In addition to discussion of COVID-19 vaccine development as it stands currently, this report examines the market for human vaccines used to prevent various types of disease, focusing on commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable, with a discussion of the demanding tasks that are facing vaccine manufacturers. “Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline” provides the following market data:

  • Worldwide Vaccine Market Revenues, 2019-2024
  • Global Vaccine Market Analysis by Country, 2019 (US, EU, Japan, China, India, RoW)
  • Major Manufacturers' Shares of the World Vaccine Market, 2019

This report examines the current global market for vaccines, including discussion of prevailing issues:

  • COVID-19 Vaccine Candidates
  • Developing World WHO Vaccine Candidates
  • Other Future Vaccine Products
  • Challenges to Vaccine Development

Vaccination has played an enormous role in the prevention of disease, having had the greatest impact on human health of any medical intervention to date. As a result, vaccine-preventable diseases and their resulting deaths are now relatively rare in the developed world. However, developing nations have not benefited as much from the introduction of vaccines. “Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline” outlines the issues and trends affecting the vaccine industry, including:

  • Increasing Life Expectancy
  • Manufacturing Incentives
  • Synthetic Vaccines
  • Artificial Intelligence Development
  • Pipeline and COVID-19 Development

The report also reviews the history and lines of business, strategic alliances and vaccine products of market participants:

  • Advaxis, Inc.
  • Bavarian Nordic, A/S
  • Bharat Biotech International Ltd.
  • CSL Limited/Seqiris
  • Emergent BioSolutions, Inc.
  • GlaxoSmithKline, Inc. (GSK)
  • Gradalis, Inc.
  • Hawaii Biotech, Inc.
  • Immune Response Biopharma, Inc.
  • Inovio, Inc.
  • Johnson & Johnson (J&J)/Crucell/Janssen
  • Medicago, Inc.
  • Merck, Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Moderna, Inc
  • Northwest Biotherapeutics, Inc.
  • NovaVax, Inc.
  • Pfizer, Inc.
  • Sanofi Pasteur
  • Serum Institute, Inc.
  • Soligenix, Inc.
  • SOTIO a.s.
  • Takeda Pharmaceutical Co, Ltd.
  • Valneva SE

Also included as an appendix is the WHO Vaccine Pipeline Tracker, a listing of WHO vaccine candidates for HIV, Ebola/Marburg, Zika, Malaria, TB and Dengue - over 400 vaccines in development.

TABLE OF CONTENTS

CHAPTER 1: EXECUTIVE SUMMARY

  • OVERVIEW
  • SCOPE AND METHODOLOGY
  • COVID-19
    • Table 1-1: Select Vaccines in Development for COVID-19
  • MARKET OVERVIEW AND POTENTIAL
    • Table 1-2: Total Worldwide Vaccine Market Revenues 2019-2024 (in billions $)
    • Table 1-3: Global Vaccine Market Analysis by Country, 2019 (in billions USD) (US, EU, Japan, China, India, RoW)
    • Table 1-4: Major Manufacturers' Shares of the World Vaccine Market, 2019 (%, $ Billions)

CHAPTER 2: INTRODUCTION TO VACCINE INDUSTRY

  • OVERVIEW
    • How Vaccines Work
    • Types of Vaccines
      • Table 2-1: Types of Vaccines
    • Regulatory Process

CHAPTER 3: PRODUCTION AND CHALLENGES OF VACCINE DEVELOPMENT

  • VACCINE DEVELOPMENT PROGRAM
    • Egg Production
    • Cellular Production
  • INFLUENZA VACCINE PRODUCTION
  • CELL-BASED INFLUENZA VACCINES
  • MANUFACTURING CHALLENGES
  • PANDEMICS
    • HIN1 Pandemic of 2009/2010
    • Coronavirus Pandemic
  • CONTRACT MANUFACTURING INVOLVEMENT

CHAPTER 4: ISSUES AND TRENDS OF THE VACCINE INDUSTRY

  • OVERVIEW
  • INCREASING LIFE EXPECTANCY
  • MANUFACTURING INCENTIVES
  • SYNTHETIC VACCINES
  • ARTIFICIAL INTELLIGENCE DEVELOPMENT
  • PIPELINE AND COVID-19 DEVELOPMENT
    • Table 4-1: Selected Vaccines in Development
    • Phase III Vaccine Trials: Status
    • Personalized Vaccines
      • Table 4-2: Selected Personalized Phase 1 and 2 Vaccine Trials 2020
    • COVID-19 Development
    • Table 4-3: Select Vaccines in Development for COVID-19

CHAPTER 5: MARKET PARTICIPANTS

  • ADVAXIS, INC
    • Table 5-1: Advaxis Corporate Summary
    • Company Summary
    • Products
  • BAVARIAN NORDIC, A/S
    • Table 5-2: Bavarian Nordic A/S Corporate Summary
    • Company Summary
    • Products
  • BHARAT BIOTECH INTERNATIONAL LTD
    • Table 5-3: Bharat Biotech Corporate Summary
    • Company Summary
  • CSL LIMITED/SEQIRIS
    • Table 5-4: CSL/Seqiris Corporate Summary
    • Company Summary
    • Products
  • EMERGENT BIOSOLUTIONS, INC
    • Table 5-5: Emergent BioSolutions Corporate Summary
    • Company Summary
    • Products
  • GLAXOSMITHKLINE, INC
    • Table 5-6: GlaxoSmithKline Corporate Summary
    • Company Summary
    • Products
      • Table 5-7: GSK Marketed Vaccines 2019
  • GRADALIS, INC
    • Table 5-8: Gradalis Corporate Summary
    • Company Summary
    • Products
  • HAWAII BIOTECH, INC
    • Table 5-9: Hawaii Biotech Corporate Summary
    • Company Summary
    • Products
  • IMMUNE RESPONSE BIOPHARMA, INC
    • Table 5-10: Immune Response Biopharma Corporate Summary
    • Company Summary
    • Products
  • INOVIO PHARMACEUTICALS, INC
    • Table 5-11: Inovio Corporate Summary
    • Company Summary
    • Products
  • JOHNSON & JOHNSON/CRUCELL/JANSSEN
    • Table 5-12: Johnson & Johnson Corporate Summary
    • Company Summary
    • Products
  • MEDICAGO, INC
    • Table 5-13: Medicago Corporate Summary
    • Company Summary
    • Products
  • MERCK & CO, INC
    • Table 5-14: Merck Corporate Summary
    • Company Summary
    • Products
  • MITSUBISHI TANABE PHARMA CORPORATION
    • Table 5-15: Mitsubishi Tanabe Corporate Summary
    • Company Summary
    • Products
  • MODERNA, INC
    • Table 5-16: Moderna Corporate Summary
    • Company Summary
    • Products
  • NORTHWEST BIOTHERAPEUTICS, INC
    • Table 5-17: Northwest BioTherapeutics Corporate Summary
    • Company Summary
    • Products
  • NOVAVAX, INC
    • Table 5-18: NovaVax Corporate Summary
    • Company Summary
    • Products
  • PFIZER, INC
    • Table 5-19: Pfizer Corporate Summary
    • Company Summary
    • Products
  • SANOFI PASTEUR
    • Table 5-20: Sanofi Pasteur Corporate Summary
    • Company Summary
    • Products
  • SERUM INSTITUTE, INC
    • Table 5-21: Serum Institute of India Corporate Summary
    • Company Summary
    • Products
  • SOLIGENIX, INC
    • Table 5-22: Soligenix Corporate Summary
    • Company Summary
    • Products
  • SOTIO A.S
    • Table 5-23: SOTIO Corporate Summary
    • Company Summary
    • Products
  • TAKEDA PHARMACEUTICAL CO, LTD
    • Table 5-24: Takeda Pharmaceutical Corporate Summary
    • Company Summary
    • Products
  • VALNEVA SE
    • Table 5-25: Valneva Corporate Summary
    • Company Summary
    • Products

APPENDIX: WHO VACCINE PIPELINE TRACKER

  • Table A-1: WHO Vaccine Pipeline Tracker
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.